Search
Search Results
##search.searchResults.foundPlural##
-
PATIENTS WITH HAEMOGLOBINOPATHIES AND CHRONIC HEPATITIS C: A REALLY DIFFICULT TO TREAT POPULATION IN 2016?
2972PDF: 997HTML: 2068Cover letter: 187 -
Brain abscesses caused by Nocardia paucivorans in a multiple myeloma patient treated with lenalidomide and dexamethasone: a case report and review of literature.
1733PDF: 1098HTML: 6524original file with images: 294 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1516PDF: 801Suppl. Files: 337Html: 141 -
PREVENTION OF POST-TRANSFUSION HEPATITIS BY SCREENING OF ANTIBODY TO HEPATITIS B CORE ANTIGEN IN HEALTHY BLOOD DONORS
1188PDF: 704HTML: 1258Title page: 217 -
PREVALENCE OF ALPHA THALASSEMIA IN MICROCYTIC ANEMIA: A TERTIARY CARE EXPERIENCE FROM NORTH INDIA
2480PDF: 1247HTML: 4756table: 218fig 1: 233fig 2: 186 -
Acquired Hemophilia A successfully treated with rituximab
2108PDF: 1164HTML: 1460Figure 1: 200 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2301PDF: 902HTML: 2010Fig 1 Rossi: 204 -
THALASSEMIA AND VENOUS THROMBOEMBOLISM
2989PDF: 1047HTML: 4608 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3628PDF: 2552HTML: 1525 -
DIAMOND BLACKFAN ANEMIA: A TERTIARY CARE CENTRE EXPERIENCE
2012PDF: 865HTML: 3599Diamond Blackfan Anemia: A Tertiary care centre experience: 322 -
NOVEL MUTATIONS IN THE NON-STRUCTURE PROTEIN 2 OF SARS-CoV-2 Sequence analysis NSP2 of SARS-CoV-2
1023PDF: 478HTML: 131 -
THE EFFECT OF ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS IN IBADAN, NIGERIA. ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS
2795PDF: 1009HTML: 81 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
748PDF: 474HTML: 6274 -
PEDIATRIC TUBERCULOSIS IN THE NORTH SARDINIA
2521PDF: 886HTML: 2396 -
THE ROLE OF THE CAROTID DOPPLER EXAMINATION IN THE EVALUATION OF ATHEROSCLEROTIC CHANGES IN BETA THALASSEMIA PATIENTS
2214PDF: 1000HTML: 3011Untitled: 223 -
-
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2291PDF: 1070HTML: 1992Characteristic of study group: 211 -
A case of iron deficiency anemia with co-existing Hb Fontainebleau.
1355PDF: 776HTML: 2078Untitled: 309 -
-
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1460PDF: 1344HTML: 109 -
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
4371PDF: 1222HTML: 2323Figure 1: 176 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3759PDF: 1643HTML: 83 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1905HTML: 1504PDF: 1125 -
PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics
829PDF: 106HTML: 149 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1634PDF: 818HTML: 1242Figure 1: 182Figure 2: 196Figure 3: 193







